title: Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus.
abstract: Canine oral papillomavirus (COPV) infection of naive beagle dogs causes oral papillomas, most of which spontaneously regress. Regressor beagles do not develop new oral papillomas because of COPV type-specific, cell-mediated immunity, COPV neutralizing antibodies, or both. Formalin-fixed native and recombinant COPV vaccines that target the systemic immune system induce neutralizing antibodies that prevent development of oral papillomas. This study was designed to determine whether spontaneously regressing mucosal papillomas also targeted the systemic immune system to induce circulating, neutralizing IgG antibodies that protect against infection by COPV. To accomplish this goal, IgG was fractionated from sera collected from weanling beagles and regressor beagles and tested for conferring protection by passive immunization. Serum was tested by ELISA for antibodies against intact virions and then pooled for passive transfer to naive beagles. Preimmune sera were neither reactive by ELISA nor protective by passive transfer. On the other hand, IgG antibodies from regressor beagles were reactive by ELISA and passive transfer conferred protection against COPV challenge. Circulating IgG antibodies induced by spontaneous regression of canine oral papillomas protect beagles against intraoral infection by COPV, a model for mucosotropic HPV.
authors.affiliation: Department of Pathology, Georgetown University School of Medicine, 3900 Reservoir Road, Washington, DC 20007, USA.
authors.forename: S
authors.initials: S
authors.lastname: Ghim
authors.forename: J
authors.initials: J
authors.lastname: Newsome
authors.forename: J
authors.initials: J
authors.lastname: Bell
authors.forename: J P
authors.initials: JP
authors.lastname: Sundberg
authors.forename: R
authors.initials: R
authors.lastname: Schlegel
authors.forename: A B
authors.initials: AB
authors.lastname: Jenson
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis* / Q000276:immunology; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000276:immunology*; D004285:Dogs / Q000276:immunology / Q000821:virology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000276:immunology; D009061:Mouth Mucosa / Q000276:immunology / Q000821:virology; D009062:Mouth Neoplasms / Q000276:immunology / Q000662:veterinary*; D009500:Neutralization Tests; D010212:Papilloma / Q000276:immunology / Q000662:veterinary*; D027383:Papillomaviridae / Q000276:immunology*; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D012075:Remission, Spontaneous; D014412:Tumor Virus Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G